Cargando…

Reduced sensitivity to delayed time and delayed reward of the post-operative insular glioma patients in delay discounting

Previous studies have shown that the insula is closely related to addiction, and the structure’s role in delay discounting can be measured by a specific task, but the specific role of the insula has been less studied. In this study, we first conducted a lesion study in which we recruited healthy con...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Wenjin, Huang, Zhenxing, Li, Jun, Dong, Qi, Li, Yang, Li, Gen, Xu, Yaokai, Xue, Bowen, Li, Zhenye, Chen, Chuansheng, Sun, Shengjun, Zhang, Yazhuo, Hou, Zonggang, Xie, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648800/
https://www.ncbi.nlm.nih.gov/pubmed/34864287
http://dx.doi.org/10.1016/j.nicl.2021.102895
Descripción
Sumario:Previous studies have shown that the insula is closely related to addiction, and the structure’s role in delay discounting can be measured by a specific task, but the specific role of the insula has been less studied. In this study, we first conducted a lesion study in which we recruited healthy controls (n = 30) and patients with unilateral insula injury (n = 16) to complete a behavioral delay discounting task. Then we conducted a functional magnetic resonance imaging (fMRI) study, and a separate group healthy volunteers (n = 51) completed a delay discounting task during the fMRI scan. The lesion study showed a significant difference between the two groups in the delay discounting task, which revealed that insula injury was associated with impaired decision making. The fMRI study revealed choice-sensitive insula activation that was modulated by delayed time and delayed reward, indicating an important role of the insula in delay discounting. Overall, our results provide evidence for a role of the insular lobe in delay discounting and suggests that this structure may be considered an important factor in the future treatment and diagnosis of addiction disorders.